載入...
Surgery for Pancreatic Cancer after neoadjuvant treatment
Pancreatic ductal adenocarcinoma (PDAC) remains to be a therapeutic challenge as only 15%‐20% of all patients present with resectable tumor stages by the time of diagnosis. In the remaining patients, either local tumor extension or systemic spread are obstacles for a surgical therapy as the only cha...
Na minha lista:
| 發表在: | Ann Gastroenterol Surg |
|---|---|
| 主要作者: | |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
John Wiley and Sons Inc.
2018
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6236102/ https://ncbi.nlm.nih.gov/pubmed/30460344 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ags3.12203 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|